Organization
Altor BioScience
3 clinical trials
Clinical trial
A Phase Ib/II Trial of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial CancerStatus: Completed, Estimated PCD: 2016-04-11
Clinical trial
A Study of ALT-801 in Patients With Relapsed or Refractory Multiple MyelomaStatus: Terminated, Estimated PCD: 2015-09-09
Clinical trial
A Phase 1/2 Study of N-803 in Patients With Relapse/Refractory Indolent B Cell Non-Hodgkin Lymphoma in Conjunction With RituximabStatus: Terminated, Estimated PCD: 2020-12-13